上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1372Please respect copyright.ＰＥＮＡＮＡ8Nbanax3hW
1372Please respect copyright.ＰＥＮＡＮＡXxcXyVRIh1
上集：https://www.penana.com/article/4711251372Please respect copyright.ＰＥＮＡＮＡk0ukplQVav
1372Please respect copyright.ＰＥＮＡＮＡfb7VHF4tjr
1372Please respect copyright.ＰＥＮＡＮＡ3ICbOUEiDI
1372Please respect copyright.ＰＥＮＡＮＡ586QgO8vin
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1372Please respect copyright.ＰＥＮＡＮＡvqcamKyRqt
1372Please respect copyright.ＰＥＮＡＮＡdOsZVAQbcn
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1372Please respect copyright.ＰＥＮＡＮＡxij2DICjG0
1372Please respect copyright.ＰＥＮＡＮＡZvAnGHT0xT
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1372Please respect copyright.ＰＥＮＡＮＡ7bdmF0D9Nm
1372Please respect copyright.ＰＥＮＡＮＡVExvhGioO5
1372Please respect copyright.ＰＥＮＡＮＡTKGIFhy5k2
1372Please respect copyright.ＰＥＮＡＮＡXK5VEK4rCU
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1372Please respect copyright.ＰＥＮＡＮＡau3eLaS3Iy
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1372Please respect copyright.ＰＥＮＡＮＡqlebWv2sJV
1372Please respect copyright.ＰＥＮＡＮＡ69H6OkSGfM
忘記甚麼是Neoantigen的話，可重溫上一集。1372Please respect copyright.ＰＥＮＡＮＡmWDjvZlrXJ
1372Please respect copyright.ＰＥＮＡＮＡ1U93Go6ftD
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1372Please respect copyright.ＰＥＮＡＮＡwJ3MRcTtXa
1372Please respect copyright.ＰＥＮＡＮＡZzrFRysLT3
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1372Please respect copyright.ＰＥＮＡＮＡTPUdZ8R5A5
1372Please respect copyright.ＰＥＮＡＮＡTLYhhz5ClF
1372Please respect copyright.ＰＥＮＡＮＡQ8jLalq3tG
1372Please respect copyright.ＰＥＮＡＮＡ0bFaFa70Ub
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1372Please respect copyright.ＰＥＮＡＮＡKqiTe5cs1B
1372Please respect copyright.ＰＥＮＡＮＡp0md8QfKWD
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1372Please respect copyright.ＰＥＮＡＮＡysbIYHArpu
1372Please respect copyright.ＰＥＮＡＮＡHSOHcOG1Xf
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1372Please respect copyright.ＰＥＮＡＮＡzPrvGg5lfV
1372Please respect copyright.ＰＥＮＡＮＡPXESQpUf8Z
1372Please respect copyright.ＰＥＮＡＮＡBKGOeutMTQ
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1372Please respect copyright.ＰＥＮＡＮＡdj80ZDOUp9
1372Please respect copyright.ＰＥＮＡＮＡtYfy9CbOKS
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1372Please respect copyright.ＰＥＮＡＮＡGm3z4zmeIo
1372Please respect copyright.ＰＥＮＡＮＡ0SLW8pYYV9
1372Please respect copyright.ＰＥＮＡＮＡYE1lNwKHBf
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1372Please respect copyright.ＰＥＮＡＮＡeOnrOUFn2f
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1372Please respect copyright.ＰＥＮＡＮＡYJlbTHwJLa
1372Please respect copyright.ＰＥＮＡＮＡ1Lj1iMOXTl
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1372Please respect copyright.ＰＥＮＡＮＡowv8NImB9X
1372Please respect copyright.ＰＥＮＡＮＡtPD3vDpFDc
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1372Please respect copyright.ＰＥＮＡＮＡ5FapnFdMMO
1372Please respect copyright.ＰＥＮＡＮＡcVnP8d6Kgs
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1372Please respect copyright.ＰＥＮＡＮＡ7OrOpe0ZQS
1372Please respect copyright.ＰＥＮＡＮＡo7JzwceNOz
1372Please respect copyright.ＰＥＮＡＮＡPqJIrBToGo
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1372Please respect copyright.ＰＥＮＡＮＡFFmRrMsDTB
1372Please respect copyright.ＰＥＮＡＮＡ9SpJRNe3Ec
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1372Please respect copyright.ＰＥＮＡＮＡ9X3j7nRO3E
1372Please respect copyright.ＰＥＮＡＮＡyM69Jo0cjl
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1372Please respect copyright.ＰＥＮＡＮＡXjmvqmFqr8
1372Please respect copyright.ＰＥＮＡＮＡSNolANnPVB
Link:1372Please respect copyright.ＰＥＮＡＮＡyOklFa5Kx0
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1372Please respect copyright.ＰＥＮＡＮＡEUingc0y8V
1372Please respect copyright.ＰＥＮＡＮＡI99Qc3b2pE
1372Please respect copyright.ＰＥＮＡＮＡGlu6sKg5Rl
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1372Please respect copyright.ＰＥＮＡＮＡBjV8aDCB8x
Penana
search
Loginarrow_drop_down
Registerarrow_drop_down
